Client News
Roquefort Therapeutics plc: Confirmation of No Exposure to Silicon Valley BankHome / Client News / Roquefort Therapeutics plc: Confirmation of No Exposure to Silicon Valley Bank
Roquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth oncology market notes the evolving situation in relation to Silicon Valley Bank (together with its UK subsidiary, collectively “SVB”).
Roquefort Therapeutics confirms that it does not have any exposure to SVB, either in relation to cash deposits, investments or debt facilities.
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
CLIENT AREA
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.